Stay updated on ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision tag updated to v3.6.6, replacing the previous v3.6.5, indicating a newer page version. No substantive study details appear to be altered by this update.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision was updated to v3.6.5, representing a minor maintenance update to the study record rather than a change to study details.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page revision label was updated to v3.6.4. This administrative update does not change the study details or how the page is used by visitors.SummaryDifference0.0%

- Check58 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, indicating a minor backend or display update. The visible study information and user actions remain unchanged.SummaryDifference0.0%

- Check65 days agoChange DetectedA broader set of keywords/MeSH terms and drug names was added to the study's metadata (e.g., Bevacizumab, Gemcitabine, Paclitaxel, Carboplatin, pegylated liposomal doxorubicin), enhancing indexing and cross-linking. The revision tag was updated from v3.6.0 to v3.6.2.SummaryDifference79%

- Check80 days agoChange DetectedNew user-focused sections and links were added to help potential participants determine eligibility, contact the study team, and learn how to join. Existing content labeling was standardized to present the Interventions/Treatment clearly.SummaryDifference0.4%

Stay in the know with updates to ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.